Stockscreener 앱 받기
1.12
10.40%
-0.13
시장 영업 전:
1.14
0.02
+1.79%
전일 마감가:
$1.25
열려 있는:
$1.23
하루 거래량:
437.00K
Relative Volume:
0.09
시가총액:
$6.71M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+2.75%
1개월 성능:
+16.86%
6개월 성능:
-98.76%
1년 성능:
+0.00%
1일 변동 폭
$1.12
$1.25
1주일 범위
$1.08
$1.28
52주 변동 폭
$0.55
$1,200.00
Polyrizon Ltd Stock (PLRZ) Company Profile
PLRZ을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PLRZ
Polyrizon Ltd
|
1.12 | 7.49M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.79 | 106.37B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
460.46 | 59.90B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.63 | 60.40B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
796.92 | 49.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.10 | 36.88B | 4.56B | -176.77M | 225.30M | -1.7177 |
Polyrizon Ltd 주식(PLRZ)의 최신 뉴스
Is Polyrizon Ltd. stock affected by interest rate hikesJuly 2025 News Drivers & AI Based Buy/Sell Signal Reports - newser.com
Will Polyrizon Ltd. stock keep outperforming rivalsMarket Sentiment Report & AI Forecast for Swing Trade Picks - newser.com
What data driven models say about Polyrizon Ltd.’s futureStock Surge & Real-Time Market Sentiment Alerts - newser.com
Applying chart zones and confluence areas to Polyrizon Ltd.2025 Growth vs Value & Free Risk Controlled Daily Trade Plans - newser.com
Analyzing Polyrizon Ltd. with multi timeframe chartsBull Run & Weekly High Potential Stock Alerts - newser.com
How Polyrizon Ltd. stock compares to growth peersWall Street Watch & Verified Momentum Watchlists - newser.com
Applying big data sentiment scoring on Polyrizon Ltd.2025 Retail Activity & Free Real-Time Market Sentiment Alerts - newser.com
Polyrizon Reports Positive Pre-Clinical Results for PL-14 Allergy Blocker - TipRanks
Published on: 2025-10-06 07:52:02 - newser.com
Polyrizon shares preclinical results for nasal allergy blocker - Investing.com
Polyrizon Announces Positive Pre-Clinical Results: PL-14 Demonstrates Encouraging Allergen-Blocking Efficacy - The Manila Times
Polyrizon shares preclinical results for nasal allergy blocker By Investing.com - Investing.com Australia
Leading vs lagging indicators on Polyrizon Ltd. performanceJuly 2025 PostEarnings & Short-Term Swing Trade Alerts - newser.com
1.07% allergen penetration at 1hr — Polyrizon PL-14 forms effective nasal barrier in preclinical study - Stock Titan
Is Polyrizon Ltd. building a consolidation baseQuarterly Profit Review & Fast Exit and Entry Strategy Plans - newser.com
Applying sector rotation models to Polyrizon Ltd.Insider Buying & Comprehensive Market Scan Insights - newser.com
Can technical indicators confirm Polyrizon Ltd.’s reversalPortfolio Performance Summary & Fast Entry High Yield Tips - newser.com
Smart tools for monitoring Polyrizon Ltd.’s price actionMarket Sentiment Report & Growth Focused Stock Reports - newser.com
How strong is Polyrizon Ltd. stock balance sheetPortfolio Update Summary & Weekly High Return Stock Opportunities - newser.com
How moving averages guide Polyrizon Ltd. tradingShare Buyback & Growth Focused Stock Reports - newser.com
What machine learning models say about Polyrizon Ltd.July 2025 EndofMonth & Safe Entry Trade Reports - newser.com
Visualizing Polyrizon Ltd. stock with heatmapsJuly 2025 Action & Daily Profit Focused Stock Screening - newser.com
Is Polyrizon Ltd. stock reversal real or fakeTreasury Yields & AI Powered Market Entry Ideas - newser.com
Published on: 2025-10-03 03:17:45 - newser.com
Is Polyrizon Ltd a good long term investmentStock Market Trends & Options Trading Analysis Tools - earlytimes.in
Polyrizon Ltd (PLRZ) 재무 분석
Polyrizon Ltd (PLRZ)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
5.74%
자본화:
|
볼륨(24시간):